Is it time to re-think juvenile-onset Rheumatic and Musculoskeletal Diseases? - First steps towards individualised treatments to meet agreed targets
| Publié dans: | Clinical immunology (Orlando, Fla.). - 1999. - 223(2021) vom: 19. Feb., Seite 108647 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | |
| Format: | Article en ligne |
| Langue: | English |
| Publié: |
2021
|
| Accès à la collection: | Clinical immunology (Orlando, Fla.) |
| Sujets: | Editorial Biomarkers Child Classification Inflammation Paediatric rheumatology Stratified Treatment Antirheumatic Agents |
| Description: | Date Completed 14.06.2021 Date Revised 14.06.2021 published: Print-Electronic Citation Status MEDLINE |
|---|---|
| ISSN: | 1521-7035 |
| DOI: | 10.1016/j.clim.2020.108647 |